A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability. - RIIP - Réseau International des Instituts Pasteur Access content directly
Journal Articles Bioorganic and Medicinal Chemistry Letters Year : 2012

A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.

Abstract

Following the previous SAR of a novel dihydropyrimidinone scaffold as HIV-1 replication inhibitors a detailed study directed towards optimizing the metabolic stability of the ester functional group in the dihydropyrimidinone (DHPM) scaffold is described. Replacement of the ester moiety by thiazole ring significantly improved the metabolic stability while retaining antiviral activity against HIV-1 replication. These novel and potent DHPMs with bioisosteres could serve as advanced leads for further optimization.

Domains

Virology

Dates and versions

pasteur-00683846 , version 1 (31-03-2012)

Identifiers

Cite

Junwon Kim, Taedong Ok, Changmin Park, Wonyoung So, Mina Jo, et al.. A novel 3,4-dihydropyrimidin-2(1H)-one: HIV-1 replication inhibitors with improved metabolic stability.. Bioorganic and Medicinal Chemistry Letters, 2012, 22 (7), pp.2522-6. ⟨10.1016/j.bmcl.2012.01.133⟩. ⟨pasteur-00683846⟩

Collections

RIIP RIIP_COREE
52 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More